Variant report
Variant | nsv895510 |
---|---|
Chromosome Location | chr10:58602006-58672533 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:58621047..58621938-chr15:50576510..50577380,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12572501 | chr10:58604639-58604640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs137864063 | chr10:58604649-58604650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs141638563 | chr10:58604655-58604656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150897446 | chr10:58604687-58604688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs75889166 | chr10:58604699-58604700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs527341859 | chr10:58604700-58604701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs192538344 | chr10:58604712-58604713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs139399957 | chr10:58604753-58604754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149650042 | chr10:58604776-58604777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191673144 | chr10:58604777-58604778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571428427 | chr10:58604799-58604800 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs150192090 | chr10:58604907-58604908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375918061 | chr10:58604929-58604930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538829645 | chr10:58604935-58604936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs11595386 | chr10:58604938-58604939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369878229 | chr10:58604940-58604941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs138040204 | chr10:58604941-58604942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs74139498 | chr10:58604944-58604945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375491193 | chr10:58604958-58604959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146121237 | chr10:58604981-58604982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184583932 | chr10:58604984-58604985 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs554917088 | chr10:58605016-58605017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576151742 | chr10:58605056-58605057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543464921 | chr10:58605066-58605067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs139559702 | chr10:58605167-58605168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532608230 | chr10:58605212-58605213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541609259 | chr10:58605223-58605224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192244062 | chr10:58605237-58605238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530402608 | chr10:58605306-58605307 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548717639 | chr10:58605310-58605311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567239315 | chr10:58605327-58605328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573451194 | chr10:58605331-58605332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117662167 | chr10:58605364-58605365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs571365000 | chr10:58605392-58605393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs78487104 | chr10:58605393-58605394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547556878 | chr10:58605403-58605404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs16909576 | chr10:58605407-58605408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534189232 | chr10:58605411-58605412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185030987 | chr10:58605466-58605467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371330953 | chr10:58605503-58605504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs77304342 | chr10:58605505-58605506 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189522794 | chr10:58605531-58605532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143649676 | chr10:58605542-58605543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78081798 | chr10:58605564-58605565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558671662 | chr10:58605598-58605599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570983192 | chr10:58605603-58605604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs538044870 | chr10:58605672-58605673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs146820502 | chr10:58605693-58605694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148500156 | chr10:58605741-58605742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs559861141 | chr10:58605776-58605777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 20858243 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:58604600-58605800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr10:58604800-58606200 | Enhancers | Adipose Nuclei | Adipose |
3 | chr10:58618600-58636000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr10:58621800-58622200 | Enhancers | Fetal Lung | lung |
5 | chr10:58626800-58627400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr10:58636000-58636200 | ZNF genes & repeats | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr10:58636200-58639800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr10:58636400-58637000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr10:58639400-58640200 | Enhancers | Fetal Lung | lung |
10 | chr10:58640200-58640800 | Flanking Active TSS | Fetal Lung | lung |
11 | chr10:58640400-58640800 | Enhancers | Adipose Nuclei | Adipose |
12 | chr10:58640400-58641200 | Enhancers | Ovary | ovary |
13 | chr10:58640600-58641200 | Enhancers | Fetal Stomach | stomach |
14 | chr10:58640800-58642000 | Enhancers | Fetal Lung | lung |
15 | chr10:58641000-58641600 | Enhancers | Fetal Kidney | kidney |
16 | chr10:58655200-58655800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |